Articles with public access mandates - Benjamin OrtizLearn more
Available somewhere: 14
Effect of dupilumab on blood eosinophil counts in patients with asthma, chronic rhinosinusitis with nasal polyps, atopic dermatitis, or eosinophilic esophagitis
ME Wechsler, AD Klion, P Paggiaro, P Nair, D Staumont-Salle, A Radwan, ...
The Journal of Allergy and Clinical Immunology: In Practice 10 (10), 2695-2709, 2022
Mandates: US National Institutes of Health
More than a decade follow-up in patients with severe or difficult-to-treat asthma: The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) II
BE Chipps, T Haselkorn, B Paknis, B Ortiz, ER Bleecker, F Kianifard, ...
Journal of Allergy and Clinical Immunology 141 (5), 1590-1597. e9, 2018
Mandates: US National Institutes of Health
Baseline FeNO independently predicts the dupilumab response in patients with moderate-to-severe asthma
ID Pavord, Y Deniz, J Corren, TB Casale, JM FitzGerald, K Izuhara, ...
The Journal of Allergy and Clinical Immunology: In Practice 11 (4), 1213 …, 2023
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Effect of omalizumab on lung function and eosinophil levels in adolescents with moderate-to-severe allergic asthma
WW Busse, M Humbert, T Haselkorn, B Ortiz, BL Trzaskoma, ...
Annals of Allergy, Asthma & Immunology 124 (2), 190-196, 2020
Mandates: UK Medical Research Council
A community-based strategy for improving asthma management and outcomes for preschoolers
SE Findley, G Thomas, R Madera-Reese, N McLeod, S Kintala, ...
Journal of Urban Health 88, 85-99, 2011
Mandates: US National Institutes of Health
Impact of baseline patient characteristics on dupilumab efficacy in type 2 asthma
WW Busse, P Paggiaro, X Muñoz, TB Casale, M Castro, GW Canonica, ...
European Respiratory Journal 58 (4), 2021
Mandates: US National Institutes of Health, Patient-Centered Outcomes Research Institute
Disease burden and long-term risk of persistent very poorly controlled asthma: TENOR II
T Haselkorn, SJ Szefler, BE Chipps, ER Bleecker, MS Harkins, B Paknis, ...
The Journal of Allergy and Clinical Immunology: In Practice 8 (7), 2243-2253, 2020
Mandates: US National Institutes of Health
Treatment benefit with omalizumab in children by indicators of asthma severity
SJ Szefler, TB Casale, T Haselkorn, B Yoo, B Ortiz, M Kattan, WW Busse
The Journal of Allergy and Clinical Immunology: In Practice 8 (8), 2673-2680. e3, 2020
Mandates: US National Institutes of Health
Pediatrician attitudes toward digital voice assistant technology use in clinical practice
JL Wilder, D Nadar, N Gujral, B Ortiz, R Stevens, F Holder-Niles, J Lee, ...
Applied clinical informatics 10 (02), 286-294, 2019
Mandates: US National Institutes of Health
Dupilumab efficacy in steroid-dependent severe asthma by baseline oral corticosteroid dose
C Domingo, JF Maspero, M Castro, NA Hanania, LB Ford, DMG Halpin, ...
The Journal of Allergy and Clinical Immunology: In Practice 10 (7), 1835-1843, 2022
Mandates: US National Institutes of Health, Patient-Centered Outcomes Research Institute
Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate‐to‐severe type 2 asthma
A Papi, J Corren, M Castro, C Domingo, L Rogers, KR Chapman, ...
Allergy 78 (1), 233-243, 2023
Mandates: US National Institutes of Health, Patient-Centered Outcomes Research Institute
Dupilumab efficacy and safety in patients with asthma and blood eosinophils≥ 500 cells· µL− 1
KF Rabe, ID Pavord, M Castro, ME Wechsler, N Daizadeh, U Kapoor, ...
European Respiratory Journal 59 (6), 2022
Mandates: US National Institutes of Health, Patient-Centered Outcomes Research Institute
Improvement in lung function with dupilumab does not predict its effects on reducing asthma exacerbation
NA Hanania, JF Maspero, DMG Halpin, DJ Jackson, RA Panettieri, ...
Journal of Asthma and Allergy, 851-854, 2022
Mandates: US National Institutes of Health, Patient-Centered Outcomes Research Institute
Predominance of Atopic Asthma in Patients with Severe or Difficult-to-Treat Asthma in the TENOR-II cohort
T Haselkorn, D Mink, F Kianifard, B Ortiz, B Paknis, J Lecocq, BE Chipps, ...
Annals of Allergy, Asthma & Immunology 127 (5), 593-595, 2021
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program